Buy 5 or More Products! Save 25% On Total.
 Buy 3 or More Products! Save 10% On Total.
 Free Shipping! No Minimum Order.

Search MPJE Updates

  •       OR/AND      
Match all words   Match any words

 

MPJE® Updates/Corrections

 

August 23, 2014  Updates/Corrections For Texas Law.  


  View Updates/Corrections

Section-1. Explanation 25 is changed:

The Texas State Board of Pharmacy consists of nine members eleven members appointed by the governor with the advice and consent of the senate as follows:

(1). six members seven members who are pharmacists;
(2). one member who is a pharmacy technician; and
(2). three members who represent the public.

Section-2. Explanation 21 is changed:

3. The prescription drug order is not dispensed after the end of the seventh day twenty-first day...

Section-3. Explanation 17 is changed:

Explanation: True False, Ratio of on-site pharmacist to pharmacy technicians and pharmacy technician trainees: The ratio of on-site pharmacists to pharmacy technicians and pharmacy technician trainees may be 1:3 1:4, provided the pharmacist is on-site and at least one of the three four is a pharmacy technician. The ratio of pharmacists to pharmacy technician trainees may not exceed 1:2 1:3.

At their February 2014, the Board voted to amend the ratio requirements for Class A, Class B,and Class G pharmacies. The ratio for pharmacists to pharmacy technicians in Class A and Class B pharmacies was increased to 1:4 and the ratio in Class G pharmacies was increased to 1:8.

Section-3. Q.28 and Explanation 28 are changed:

Which of the following shall require on a prescription of controlled substance signed by an advanced practice nurse?

I. name, original signature and the DEA number identification number of the advanced practice nurse.
II. name, address, telephone number of the supervising practitioner.
III. the DEA number of the supervising practitioner.
IV.III. address and telephone number of the clinic at which the prescription drug order was signed.

a.I and IV only a. I only
b.I, III and IV only b. I and II only
c.II and III only
d. All

A.28: (ii). name, address, telephone number, and if the prescription is for a controlled substance, the DEA number of the supervising practitioner;
(iii). name, original signature and if the prescription is for a controlled substance, the DEA number identification number of the advanced practice nurse or physician assistant;

Section-4. Explanation 19 is changed:

(C). An electronic transfer between pharmacies may be initiated by a pharmacist intern , pharmacy technician, or pharmacy technician trainee acting under the direct supervision of a pharmacist.

Section-4. Explanation 21 is changed:

The ratio of on-site pharmacists to pharmacy technicians and pharmacy technician trainees may be 1:3 1:4, provided the pharmacist is on-site and at least one of the three four is a pharmacy technician. The ratio of pharmacists to pharmacy technician trainees may not exceed 1:2 1:3.

Section-5. Question 5 is changed:

c. should not be filled by the pharmacist under any circumstances.
c. should only be filled by the pharmacist if the physician assistant is working for a hospital.

Section-5. Explanation 30 is changed:

Answer: I only. All.

2. NP (Nurse Practitioner): Schedule III to V controlled substances prescribe and administer (30 days supply only). Schedule II Prescribing and Ordering Only for Hospital/Hospice.
3. PA (Physician assistants): Schedule III to V controlled substances prescribe and administer (30 days supply only). Schedule II Prescribing and Ordering Only for Hospital/Hospice.
 


close
 

August 20, 2014  Updates/Corrections For West Virginia Law.  


  View Updates/Corrections

Section-1. Q.23 Question and Explanation 23 are changed:

Q. 23. Any person who within any thirty-day period knowingly purchases, receives or otherwise possesses more than three packages of a drug product containing as its single active ingredient ephedrine, pseudoephedrine or phenylpropanolamine, or more than nine grams of ephedrine, pseudoephedrine or phenylpropanolamine in any form, shall be guilty of a misdemeanor according to West Virginia State Pharmacy Law.

A.23 True, Any person who within any thirty-day period knowingly purchases, receives or otherwise possesses more than three packages of a drug product containing as its single active ingredient ephedrine, pseudoephedrine or phenylpropanolamine, or more than nine grams of ephedrine, pseudoephedrine or phenylpropanolamine in any form, shall be guilty of a misdemeanor according to West Virginia State Pharmacy Law.

Q.23 Any person who within any 30-day period knowingly purchases, receives or otherwise possesses more than 7.2 grams of ephedrine, pseudoephedrine or phenylpropanolamine in any form without a prescription, shall be guilty of a misdemeanor according to West Virginia State Pharmacy Law.

A.23 True. A pharmacy may not sell, transfer or dispense to the same person, and a person may not purchase more than 3.6 grams per day, more than 7.2 grams in a 30-day period or more than 48 grams annually of ephedrine, pseudoephedrine or phenylpropanolamine without a prescription. The limits shall apply to the total amount of ephedrine, pseudoephedrine and phenylpropanolamine contained in the products, and not the overall weight of the products.


close
 

August 11, 2014  Updates/Corrections For Florida Law.  


  View Updates/Corrections

Section-1. Q.1 Explanation 1 is changed:

The Board of Pharmacy is created within the department and shall consist of nine members to be appointed by the Governor and confirmed by the Senate [Florida Pharmacy Act 465.004(1)].

Seven members of the board must be licensed pharmacists who are residents of this state and who have been engaged in the practice of the profession of pharmacy in this state for at least 4 years and, to the extent practicable, represent the various pharmacy practice settings.

Of the pharmacist members, one two must be currently engaged in the practice of pharmacy in a community pharmacy, one two must be currently engaged in the practice of pharmacy in a Class II institutional pharmacy or a Modified Class II institutional pharmacy, and five three must be pharmacists licensed in this state irrespective of practice setting.

The remaining two members must be residents of the state who have never been licensed as pharmacists and who are in no way connected with the practice of the profession of pharmacy.

No person may be appointed as a consumer member who is in any way connected with a drug manufacturer or wholesaler. At least one member of the board must be 60 years of age or older.

The Governor shall appoint members to the board in accordance with this subsection as members' terms expire or as a vacancy occurs until the composition of the board complies with the requirements of this subsection.

Section-1 Q. 12 Explanation 12 is changed:

Each pharmacist shall retain documentation of participation in continuing education programs required for license renewal for not less than TWO FOUR years after the license is renewed for audit purposes if and when such audit is undertaken by the Department of Health and the Board of Pharmacy.

Section-1 Q. 20 Explanation 20 is changed:

This method of destruction does not require prior approval from D.E.A., but does require that a copy of the completed and witnessed D.E.A. Form 41 be mailed to D.E.A. Immediately within one (1) business day after destruction.


Section-4 Q. 24 Question 24 is changed:

Under Florida State Pharmacy Law, no person shall knowingly deliver in any single day, any number of packages that contain a total of 3.6 grams of ephedrine or related compounds.

Under Florida State Pharmacy Law, no person shall knowingly deliver in any single day, any number of packages that contain a total in excess Of of 3.6 grams of ephedrine or related compounds.


Section-4 Q. 25 Explanation 25 is changed:

(a). Influenza vaccine.
(b). Pneumococcal vaccine.


(a). Influenza vaccine.
(b). Pneumococcal vaccine.
(c). Meningococcal vaccine.
(d). Shingles vaccine.


close
 

August 7, 2014  Plan B age restriction is removed.  


  View Updates/Corrections

Plan B One-Step, an emergency contraceptive, has been approved for unrestricted sales by the FDA after months of back-and-forth political battles between the Obama administration and federal courts. The morning-after pill is finally going over-the-counter. The Food and Drug Administration on Thursday approved unrestricted sales of Plan B One-Step, lifting all age limits on the emergency contraceptive.


close
 

August 5, 2014 Tramadol (Ultram) is now a schedule IV controlled drug.  


  View Updates/Corrections

Under a final rule (PDF) published in the Federal Register, the pain reliever tramadol is now classified as a Schedule IV controlled substance (CS). Starting August 18, 2014, Drug Enforcement Administration (DEA) will require manufacturers to print the "C-IV" designation on all labels that contain 2- [(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol (tramadol), including its salts, isomers, and salts of isomers.

The agency notes that every "DEA registrant who possesses any quantity of tramadol on the effective date of this final rule must take an inventory of all stocks of tramadol on hand as of August 18, 2014, pursuant to 21 U.S.C. 827 and 958, and in accordance with 21 CFR 1304.03,1304.04, and 1304.11 (a) and (d)." In addition, all "prescriptions for tramadol or products containing tramadol must comply with 21 U.S.C. 829, and be issued in accordance with 21 CFR part 1306 and subpart C of 21 CFR part 1311 as of August 18, 2014."

National Association of State Controlled Substances Authorities notes (PDF) that several states have already classified tramadol as a CS. To "provide a reasonable time for registrants to comply with the handling requirements" for a Schedule IV CS, DEA established the effective date of the final rule as 45 days from the date of publication.


close
 

January 14, 2018  North Carloina State Pharmacy Law Updates/Corrections


  View Updates/Corrections

Section 4 Question 9 Answer and Answer Explanation Are Updated.

The dispenser shall report the information required under the controlled substances reporting system no later than three business days after the day when the prescription was delivered.
 
a. True
b. False
 
Answer: (a) True False, [NC Controlled Substances Act and Regulations  90-113.73(a)].
 
The Department shall establish and maintain a reporting system of prescriptions for all Schedule II through V controlled substances. Each dispenser shall submit the information in accordance with transmission methods and frequency established by rule by the Commission.
 
The Department may issue a waiver to a dispenser who is unable to submit prescription information by electronic means. The waiver may permit the dispenser to submit prescription information by paper form or other means, provided all information required of electronically submitted data is submitted.
 
The dispenser shall report the information required under this section no later than the three business days after the day when the prescription was delivered (begin counting the next day after the delivery date); however, dispensers are encouraged to report the information no later than 24 hours after the prescription was delivered.
 
The dispenser shall report the information required under this section no later than the close of the next business day after the prescription is delivered; however, dispensers are encouraged to report the information no later than 24 hours after the prescription was delivered.
 
The information shall be submitted in a format as determined annually by the Department based on the format used in the majority of the states operating a controlled substance reporting system.



close


page  < 1 2 3 4 5 6 7 8 9 10



Free USA Shipping! No Minimum Order.
Free International Shipping! Over $350 or More.